LXRX

Lexicon Pharmaceuticals Stock Price

4.88
0.04 (0.83%)
Upgrade to Real-Time
Afterhours (Closed)
4.88

Low
1.03

52 Week Range

High
9.65

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Lexicon Pharmaceuticals Inc LXRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.04 0.83% 4.88 20:00:00
Open Price Low Price High Price Close Price Prev Close
4.78 4.71 4.97 4.88 4.84
Bid Price Ask Price Spread News
4.24 5.00 0.76 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6,473 882,076 $ 4.84 $ 4,269,834 11,442,177 1.03 - 9.65
Last Trade Time Type Quantity Stock Price Currency
18:16:37 3 $ 4.88 USD

Lexicon Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 690.50M 141.50M 63.29M $ 322.07M $ - 1.09 -8.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Lexicon Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LXRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.115.464.715.09841,632-0.23-4.5%
1 Month6.516.544.715.57852,218-1.63-25.04%
3 Months8.399.654.717.431,547,476-3.51-41.84%
6 Months1.429.651.034.616,322,7793.46243.66%
1 Year1.919.651.034.143,753,4202.97155.5%
3 Years8.2913.971.034.371,914,538-3.41-41.13%
5 Years13.9919.621.036.241,434,860-9.11-65.12%

Lexicon Pharmaceuticals Description

Lexicon Pharmaceuticals Inc is a biopharmaceutical company developing medicines that transform patients' lives. The company commercializes and develops drugs and drug candidates. Its drugs candidates include XERMELO (telotristat ethyl), an orally-delivered small molecule drug, in the United States for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog, or SSA, therapy in adults inadequately controlled by SSA therapy; Zynquista (sotagliflozin), an orally-delivered small molecule drug candidate, as a treatment for type 1 diabetes; sotagliflozin as a treatment for type 2 diabetes, heart failure and chronic kidney disease; and LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain.


Your Recent History
NASDAQ
LXRX
Lexicon Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.